Oral Vancomycin or Ursodeoxycholic Acid for Pediatric Primary Sclerosing Cholangitis? The Uncontroversial Need for Randomized Controlled Trials

被引：5
|
作者：
Assis, David N. [1 ]
Levy, Cynthia [2 ]
机构：
[1] Yale Sch Med, Sect Digest Dis, Dept Med, New Haven, CT USA
[2] Univ Miami, Div Digest Hlth & Liver Dis, 1500 Northwest 12th Ave,Suite 1101, Miami, FL 33136 USA
来源：
HEPATOLOGY | 2021年 / 73卷 / 03期
关键词：
D O I：
10.1002/hep.31702
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：887 / 889
页数：3
相关论文
共 50 条
  • [1] Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis
    Deneau, Mark R.
    Mack, Cara
    Mogul, Douglas
    Perito, Emily R.
    Valentino, Pamela L.
    Amir, Achiya Z.
    DiGuglielmo, Matthew
    Draijer, Laura G.
    El-Matary, Wael
    Furuya, Katryn N.
    Gupta, Nitika
    Hochberg, Jessica T.
    Horslen, Simon
    Jensen, M. Kyle
    Jonas, Maureen M.
    Kerkar, Nanda
    Koot, Bart G. P.
    Laborda, Trevor J.
    Lee, Christine K.
    Loomes, Kathleen M.
    Martinez, Mercedes
    Miethke, Alexander
    Miloh, Tamir
    Mohammad, Saeed
    Ovchinsky, Nadia
    Rao, Girish
    Ricciuto, Amanda
    Sathya, Pushpa
    Schwarz, Kathleen B.
    Shah, Uzma
    Singh, Ruchi
    Vitola, Bernadette
    Zizzo, Andreanne
    Guthery, Stephen L.
    HEPATOLOGY, 2021, 73 (03) : 1061 - 1073
  • [2] Ursodeoxycholic acid in primary sclerosing cholangitis: meta-analysis of randomized controlled trials
    Shi, Jian
    Li, Zhi
    Zeng, Xin
    Lin, Yong
    Xie, Wei-Fen
    HEPATOLOGY RESEARCH, 2009, 39 (09) : 865 - 873
  • [3] The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis
    Halma, Jennifer Christine
    Cristoferi, Laura
    Carbone, Marco
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (10) : 2699 - 2700
  • [4] Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis:: A randomized placebo-controlled trial
    Färkkilä, M
    Karvonen, AL
    Nurmi, H
    Nuutinen, H
    Taavitsainen, M
    Pikkarainen, P
    Kärkkäinen, P
    HEPATOLOGY, 2004, 40 (06) : 1379 - 1386
  • [5] The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis Reply
    Zigmond, Ehud
    Schramm, Christoph
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (10) : 2700 - 2700
  • [6] EFFECT OF URSODEOXYCHOLIC ACID IN PRIMARY SCLEROSING CHOLANGITIS - A CONTROLLED TRIAL
    BEUERS, U
    SPENGLER, U
    KRUIS, W
    AYDEMIR, U
    HELDWEIN, W
    WEINZIERL, M
    PAPE, GR
    SAUERBRUCH, T
    PAUMGARTNER, G
    HEPATOLOGY, 1991, 14 (04) : A64 - A64
  • [7] URSODEOXYCHOLIC ACID FOR PRIMARY SCLEROSING CHOLANGITIS
    CHAZOUILLERES, O
    POUPON, R
    CAPRON, JP
    METMAN, EH
    DHUMEAUX, D
    AMOURETTI, M
    COUZIGOU, P
    LABAYLE, D
    TRINCHET, JC
    JOURNAL OF HEPATOLOGY, 1990, 11 (01) : 120 - 123
  • [8] Ursodeoxycholic acid in primary sclerosing cholangitis
    Triantos, C. K.
    Koukias, N.
    Nikolopoulou, V.
    Burroughs, A. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (05) : 622 - 623
  • [9] URSODEOXYCHOLIC ACID IN THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS
    STIEHL, A
    ANNALS OF MEDICINE, 1994, 26 (05) : 345 - 349
  • [10] Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis
    Stiehl, A
    ITALIAN JOURNAL OF GASTROENTEROLOGY, 1996, 28 (03): : 178 - 180
12345